Regis Healthcare Limited (REG.XA)
- Previous Close
6.75 - Open
6.75 - Bid 6.74 x --
- Ask 6.75 x --
- Day's Range
6.68 - 6.90 - 52 Week Range
3.74 - 6.94 - Volume
71,608 - Avg. Volume
167,150 - Market Cap (intraday)
-- - Beta (5Y Monthly) 1.43
- PE Ratio (TTM)
259.58 - EPS (TTM)
0.03 - Earnings Date Feb 24, 2025
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Regis Healthcare Limited engages in the provision of residential aged care services in Australia. It provides aged care services, including ageing-in-place, respite care, specialist dementia care, and palliative care services through operation of aged care homes located in Victoria, Queensland, New South Wales, South Australia, Tasmania, Northern Territory and Western Australia. The company also offers home care services, such as personal care, nursing, help around your home, transport, shopping, companionship, overnight sleepovers, cleaning, and cooking and meal preparation. In addition, it is involved in the provision of short-term care solutions for interim assistance, and short-term and long-term temporary stays at company's residences; and ownership and operation of specialist retirement and independent living villages in Blackburn South, Norwood, and Queensland. The company was formerly known as Fairway Investment Holdings Pty Ltd. and changed its name to Regis Healthcare Limited in 2014. Regis Healthcare Limited was founded in 1994 and is based in Camberwell, Australia.
www.regis.com.au11,000
Full Time Employees
June 30
Fiscal Year Ends
--
Sector
--
Industry
Recent News: REG.XA
View MorePerformance Overview: REG.XA
Trailing total returns as of 4/27/2025, which may include dividends or other distributions. Benchmark is MSCI WORLD (^990100-USD-STRD) .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: REG.XA
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: REG.XA
View MoreValuation Measures
Market Cap
--
Enterprise Value
--
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
1.37%
Return on Assets (ttm)
0.77%
Return on Equity (ttm)
--
Revenue (ttm)
1.1B
Net Income Avi to Common (ttm)
15.09M
Diluted EPS (ttm)
0.03
Balance Sheet and Cash Flow
Total Cash (mrq)
179.92M
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
236.8M